October 12, 2012 — Water diffusion measurements with magnetic resonance imaging (MRI) could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology.

The American Society for Radiation Oncology (ASTRO) has named Mark P. Carol, M.D., a distinguished leader in the fields of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), as its 2012 Honorary Member, which is the highest honor the society bestows upon distinguished cancer researchers and leaders in disciplines other than radiation oncology, radiation physics or radiobiology. Carol will be recognized with this honor during the Awards Ceremony on Tuesday, Oct. 30, 2012, at 10:45 a.m., at ASTRO’s 54th Annual Meeting, Oct. 28 to 31, 2012, at the Boston Convention and Exhibition Center.

October 11, 2012 — Tranzbyte Corp. signed a preliminary agreement to acquire the North and South American marketing rights to one of the world's least expensive and most practical magnetic resonance imaging (MRI) machines, the Cirrus MRI from Hurricane Enterprises Ltd., a Hong Kong company.

October 11, 2012 — In a new report from Sectra, 150 neurologists, neurosurgeons, urologists, orthopedists, internists and general surgeons reveal what radiology needs to focus on in order to provide quality service to referring physicians.

October 10, 2012 — El Camino Hospital announced it is the first facility in the San Francisco Bay Area to adopt Volpara breast density measurement software from Matakina Intl. The hospital’s breast health center is among the latest California breast imaging facilities that have adopted the objective breast density assessment tool designed to improve early detection among women with dense breasts, including Sutter Health Foundation Women’s Center in Santa Rosa and North Valley Breast Clinic in Redding.

October 5, 2012 — Judge Victoria Kaufman of the U.S. Bankruptcy Court for the Central District of California (San Fernando Valley Division) approved Gamma Medica Inc.’s $1.5 million debtor-in-possession (DIP) financing on a final basis on Oct. 3 as part of its Chapter 11 restructuring. This DIP financing order provides the molecular breast imaging (MBI) manufacturer with sufficient financing to pursue a reorganization or asset sale.